First Time Loading...

DiaMedica Therapeutics Inc
NASDAQ:DMAC

Watchlist Manager
DiaMedica Therapeutics Inc Logo
DiaMedica Therapeutics Inc
NASDAQ:DMAC
Watchlist
Price: 2.85 USD -1.04% Market Closed
Updated: May 29, 2024

DiaMedica Therapeutics Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DiaMedica Therapeutics Inc
Free Cash Flow Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
DiaMedica Therapeutics Inc
NASDAQ:DMAC
Free Cash Flow
-$20.3m
CAGR 3-Years
-24%
CAGR 5-Years
-21%
CAGR 10-Years
-15%
Abbvie Inc
NYSE:ABBV
Free Cash Flow
$21.9B
CAGR 3-Years
7%
CAGR 5-Years
11%
CAGR 10-Years
16%
Gilead Sciences Inc
NASDAQ:GILD
Free Cash Flow
$7.9B
CAGR 3-Years
-3%
CAGR 5-Years
3%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Free Cash Flow
$7.1B
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Free Cash Flow
$3.5B
CAGR 3-Years
5%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Free Cash Flow
$3.9B
CAGR 3-Years
25%
CAGR 5-Years
13%
CAGR 10-Years
27%

See Also

What is DiaMedica Therapeutics Inc's Free Cash Flow?
Free Cash Flow
-20.3m USD

Based on the financial report for Mar 31, 2024, DiaMedica Therapeutics Inc's Free Cash Flow amounts to -20.3m USD.

What is DiaMedica Therapeutics Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-15%

Over the last year, the Free Cash Flow growth was -59%. The average annual Free Cash Flow growth rates for DiaMedica Therapeutics Inc have been -24% over the past three years , -21% over the past five years , and -15% over the past ten years .